0.11 USD
▼-0.01-4.50%
盘后 0.11 0.00%
2026-11-20
市值
$4.57M
市盈率
—
EPS
-1.24
股息率
—
52 周区间
0.11 – 1.82
成交量
1.26M
Beta
1.31
目标价
4.25
52W 低 0.1152W 高 1.82
价格走势
公司简介
AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company’s flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. It is also ...